Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.

Amid regional market momentum, the global bank has a strong pipeline of Apac deals across ECM, DCM and M&A.

The fundraise includes $1.8bn for KKR Asia Credit Opportunities Fund II as the investment giant sees growing investor demand for allocation to private credit in the region; the fund has been used for deals in Hong Kong, India and Australia.

In a positive year for the region's banks, 2025 ECM fees in Apac, ex Japan, were up 45% from 2024, DCM fees saw 11% growth, amid a record year for bonds, while M&A advisory fees climbed 43%.

Sydney-based Ellis has been leading the Australia & New Zealand rates sales franchise and will continue in this role.

Samantha Horton, group chief operating officer and head of international at Syfe, explained to FA some of the mechanics, challenges and attractions of the 2025 deal for the listed firm, and also future regional expansion plans.

Loan defaults in Bangladeshi's banking sector have reached an all-time high of 35.7% of total disbursed loans, posing a severe threat to depositors; elections will take place in February 2026.

The Chinese property giant's debt woes will not seriously affect China’s property sector, according to analysts; however, a restructuring might be on the cards.

The spun off firm from JD.com is preparing for an initial public offering on the Hong Kong Stock Exchange on December 11; the deal could generate around $20m of fees.

It is the Canadian giant's first renewables investments in the Philippines, Vietnam and Thailand, and follows a recent JV in Malaysia.